XB-ART-58159
Int J Mol Sci
2021 Apr 29;229:. doi: 10.3390/ijms22094728.
Show Gene links
Show Anatomy links
The Multifaceted Roles of USP15 in Signal Transduction.
Das T
,
Song EJ
,
Kim EE
.
???displayArticle.abstract???
Ubiquitination and deubiquitination are protein post-translational modification processes that have been recognized as crucial mediators of many complex cellular networks, including maintaining ubiquitin homeostasis, controlling protein stability, and regulating several signaling pathways. Therefore, some of the enzymes involved in ubiquitination and deubiquitination, particularly E3 ligases and deubiquitinases, have attracted attention for drug discovery. Here, we review recent findings on USP15, one of the deubiquitinases, which regulates diverse signaling pathways by deubiquitinating vital target proteins. Even though several basic previous studies have uncovered the versatile roles of USP15 in different signaling networks, those have not yet been systematically and specifically reviewed, which can provide important information about possible disease markers and clinical applications. This review will provide a comprehensive overview of our current understanding of the regulatory mechanisms of USP15 on different signaling pathways for which dynamic reverse ubiquitination is a key regulator.
???displayArticle.pubmedLink??? 33946990
???displayArticle.link??? Int J Mol Sci
???displayArticle.grants??? [+]
2017R1A2B3007224 Ministry of Science and ICT, 2019R1A2C2004052 Ministry of Science and ICT, 2020R1A4A4079494 Ministry of Science and ICT, 2017HID3A1A02054608 National Research Foundation of Korea
Species referenced: Xenopus laevis
Genes referenced: mdm2 smad4 smad6.2 smad7 smurf1 smurf2 tp53 usp15
???attribute.lit??? ???displayArticles.show???
![]() |
Figure 1. USP15 in the regulation of TGF-β and BMP signaling. (a) USP15 binds to SMAD7 and opposes SMURF2-mediated ubiquitination of TβRI. The deubiquitination and stabilization of TβRI by USP15 promotes TGF-β activity and triggers the downstream gene expression to stimulate cell proliferation, migration wound healing, and glioblastoma pathogenesis [13]. (b) Upon activation by BMP ligands, the receptor-regulated R-SMADs undergo phosphorylation, bind to SMAD4, and enter the nucleus to induce target gene transcription. SMAD6 is a negative regulator that competes with SMAD4 to bind to R-SMADs and induces SMURF1-mediated ubiquitination and degradation of R-SMADs. Through its interaction with SMAD6, USP15 deubiquitinates and stabilizes BMPR1 and R-SMADs to enhance the BMP signaling and elicit target gene expression [39] |
![]() |
Figure 2. USP15 suppresses TNFα and Wnt signaling in association with CSN. Upon stimulation by TNFα, NF-ĸB is activated through phosphorylation and ubiquitin-dependent degradation of IĸB by CRL/SCFβTrCP E3 ubiquitin ligase to turn on its downstream target genes. USP15, in association with CSN, deubiquitinates and promotes IĸB stabilization by inhibiting CRL/SCFβTrCP activity and hinders NF-ĸB signaling (left) [33]. USP15 negatively regulates Wnt/β-catenin signaling by promoting the formation of the β-catenin destruction complex. In association with CSN, USP15 deubiquitinates and induces the stability of the essential component of the β-catenin destruction complex APC, which is required to target the phosphorylated β-catenin for CRLβ-TrCP-dependent proteasomal degradation (right) [35]. |
![]() |
Figure 3. Regulation of p53 signaling by USP15. USP15 translation is upregulated by TGF-β through the PI3K/AKT pathway, which in turn increases the stabilization of p53 by its deubiquitination and activates p53 signaling. In another way, USP15 also promotes the ubiquitin-dependent degradation of p53 by deubiquitination and enhanced stabilization of the E3 ubiquitin ligase for p53, MDM2, resulting in the downregulation of p53 target gene expression [34,84]. |
References [+] :
Akhurst,
TGF-beta signaling in cancer--a double-edged sword.
2001, Pubmed
Akhurst, TGF-beta signaling in cancer--a double-edged sword. 2001, Pubmed
Al-Salihi, USP11 augments TGFβ signalling by deubiquitylating ALK5. 2012, Pubmed
Bardehle, Finding the 'ubiquitous' threads in infection and autoimmune neuroinflammation. 2016, Pubmed
Besche, Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. 2014, Pubmed
Chen, Inhibition of USP15 Prevent Glutamate-Induced Oxidative Damage by Activating Nrf2/HO-1 Signaling Pathway in HT22 Cells. 2020, Pubmed
Chou, The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases. 2017, Pubmed
Clague, Deubiquitylases from genes to organism. 2013, Pubmed
Clague, Breaking the chains: deubiquitylating enzyme specificity begets function. 2019, Pubmed
Clerici, The DUSP-Ubl domain of USP4 enhances its catalytic efficiency by promoting ubiquitin exchange. 2014, Pubmed
Clevers, Wnt/beta-catenin signaling in development and disease. 2006, Pubmed
Cornelissen, The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. 2014, Pubmed
D'Andrea, Deubiquitinating enzymes: a new class of biological regulators. 1998, Pubmed
Das, Phosphorylation of USP15 and USP4 Regulates Localization and Spliceosomal Deubiquitination. 2019, Pubmed
Das, Regulation of Deubiquitinating Enzymes by Post-Translational Modifications. 2020, Pubmed
Das, USP15 regulates dynamic protein-protein interactions of the spliceosome through deubiquitination of PRP31. 2017, Pubmed
Dubiel, The COP9 Signalosome: A Multi-DUB Complex. 2020, Pubmed
Eichhorn, USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. 2012, Pubmed
Elliott, Structural variability of the ubiquitin specific protease DUSP-UBL double domains. 2011, Pubmed
Fan, USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. 2011, Pubmed
Feng, Expression of USP15, TβR-I and Smad7 in psoriasis. 2014, Pubmed
Fielding, The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity. 2018, Pubmed
Fukushima, USP15 attenuates IGF-I signaling by antagonizing Nedd4-induced IRS-2 ubiquitination. 2017, Pubmed
Galant, Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β. 2019, Pubmed
Glickman, The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. 2002, Pubmed
Grabbe, The spatial and temporal organization of ubiquitin networks. 2011, Pubmed
Greenblatt, MEKK2 mediates an alternative β-catenin pathway that promotes bone formation. 2016, Pubmed
Guo, Ubiquitin specific peptidase 4 stabilizes interferon regulatory factor protein and promotes its function to facilitate interleukin-4 expression in T helper type 2 cells. 2017, Pubmed
Harper, Structure of the USP15 N-terminal domains: a β-hairpin mediates close association between the DUSP and UBL domains. 2011, Pubmed
Harper, Structure and catalytic regulatory function of ubiquitin specific protease 11 N-terminal and ubiquitin-like domains. 2014, Pubmed
Harrigan, Deubiquitylating enzymes and drug discovery: emerging opportunities. 2018, Pubmed
Hayden, Shared principles in NF-kappaB signaling. 2008, Pubmed
Heideker, DUBs, the regulation of cell identity and disease. 2015, Pubmed
Herhaus, USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling. 2014, Pubmed , Xenbase
Hershko, Basic Medical Research Award. The ubiquitin system. 2000, Pubmed
Hetfeld, The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1. 2005, Pubmed
Hu, Spotlight on USP4: Structure, Function, and Regulation. 2021, Pubmed
Huang, The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15. 2009, Pubmed
Inn, Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. 2011, Pubmed
Inoue, Regulation of TGF-beta family signaling by E3 ubiquitin ligases. 2008, Pubmed
Inui, USP15 is a deubiquitylating enzyme for receptor-activated SMADs. 2011, Pubmed , Xenbase
Iyengar, USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination. 2015, Pubmed
Jones, Insulin-like growth factors and their binding proteins: biological actions. 1995, Pubmed
Karin, Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. 2000, Pubmed
Ke, USP11 regulates p53 stability by deubiquitinating p53. 2014, Pubmed
Klein, Biochemistry and regulation of signal transduction by neuronal acetylcholine receptors. 1984, Pubmed
Koivusalo, Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists. 2006, Pubmed
Komander, Breaking the chains: structure and function of the deubiquitinases. 2009, Pubmed
Kotani, Alternative exon skipping biases substrate preference of the deubiquitylase USP15 for mysterin/RNF213, the moyamoya disease susceptibility factor. 2017, Pubmed
Lai, Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy. 2020, Pubmed
Lee, Roles of COP9 signalosome in cancer. 2011, Pubmed
Leeman, Alternative splicing in the NF-kappaB signaling pathway. 2008, Pubmed
Li, Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation. 2019, Pubmed
Li, Roles of Multifunctional COP9 Signalosome Complex in Cell Fate and Implications for Drug Discovery. 2017, Pubmed
Li, USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2. 2016, Pubmed
Lin, USP4 interacts and positively regulates IRF8 function via K48-linked deubiquitination in regulatory T cells. 2017, Pubmed
Liu, TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability. 2017, Pubmed
Lynch, Regulation of alternative splicing by signal transduction pathways. 2007, Pubmed
Massagué, Smad transcription factors. 2005, Pubmed
Meister, COP9 Signalosome Interaction with UspA/Usp15 Deubiquitinase Controls VeA-Mediated Fungal Multicellular Development. 2019, Pubmed
Menzies, Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. 2010, Pubmed
Mevissen, Mechanisms of Deubiquitinase Specificity and Regulation. 2017, Pubmed
Niederkorn, TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis. 2020, Pubmed
Oikonomaki, Ubiquitin Specific Peptidase 15 (USP15) suppresses glioblastoma cell growth via stabilization of HECTD1 E3 ligase attenuating WNT pathway activity. 2017, Pubmed
Padmanabhan, USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells. 2018, Pubmed
Park, PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression. 2019, Pubmed
Park, Structural basis for recruiting and shuttling of the spliceosomal deubiquitinase USP4 by SART3. 2016, Pubmed
Park, Tissue-specificity, functional characterization and subcellular localization of a rat ubiquitin-specific processing protease, UBP109, whose mRNA expression is developmentally regulated. 2000, Pubmed
Pauli, The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. 2014, Pubmed
Peng, The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors. 2019, Pubmed
Pfoh, Deubiquitinases and the new therapeutic opportunities offered to cancer. 2015, Pubmed
Pollak, Insulin and insulin-like growth factor signalling in neoplasia. 2008, Pubmed
Poondla, Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities? 2019, Pubmed
Reyes-Turcu, Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. 2009, Pubmed
Rozen, Exposing the subunit diversity within protein complexes: a mass spectrometry approach. 2013, Pubmed
Schauer, Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors. 2020, Pubmed
Schnell, Non-traditional functions of ubiquitin and ubiquitin-binding proteins. 2003, Pubmed
Schwechheimer, COP9 signalosome revisited: a novel mediator of protein degradation. 2001, Pubmed
Schweitzer, CSN-associated USP48 confers stability to nuclear NF-κB/RelA by trimming K48-linked Ub-chains. 2015, Pubmed
Schweitzer, CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. 2007, Pubmed
Schweitzer, Control of NF-kappaB activation by the COP9 signalosome. 2010, Pubmed
Song, The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. 2010, Pubmed
Srihari, Systematic tracking of dysregulated modules identifies novel genes in cancer. 2013, Pubmed
Sun, USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalpha. 2010, Pubmed
Tanguturi, The role of deubiquitinating enzymes in cancer drug resistance. 2020, Pubmed
Teyra, Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15. 2019, Pubmed
Torre, USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation. 2017, Pubmed
Tse, Zebrafish transforming growth factor-β-stimulated clone 22 domain 3 (TSC22D3) plays critical roles in Bmp-dependent dorsoventral patterning via two deubiquitylating enzymes Usp15 and Otud4. 2013, Pubmed
Tse, Genome-wide loss-of-function analysis of deubiquitylating enzymes for zebrafish development. 2009, Pubmed
Villeneuve, USP15 negatively regulates Nrf2 through deubiquitination of Keap1. 2013, Pubmed
Vlasschaert, Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11. 2015, Pubmed
Vos, The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability. 2009, Pubmed
Ward, The structure of the deubiquitinase USP15 reveals a misaligned catalytic triad and an open ubiquitin-binding channel. 2018, Pubmed
White, IRS proteins and the common path to diabetes. 2002, Pubmed
Wicks, Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway. 2006, Pubmed
Wrana, TGF beta signals through a heteromeric protein kinase receptor complex. 1992, Pubmed
Xiao, Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration. 2012, Pubmed
Xie, CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer. 2010, Pubmed
Xu, USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis. 2009, Pubmed
Yamaguchi, The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha). 2007, Pubmed
Yang, Deubiquitinases as pivotal regulators of T cell functions. 2018, Pubmed
Yun, Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer. 2015, Pubmed
Zhang, The regulation of TGF-β/SMAD signaling by protein deubiquitination. 2014, Pubmed
Zhang, USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. 2011, Pubmed
Zhang, RNF12 controls embryonic stem cell fate and morphogenesis in zebrafish embryos by targeting Smad7 for degradation. 2012, Pubmed
Zhang, Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. 2005, Pubmed
Zhang, Structural Basis of the Recruitment of Ubiquitin-specific Protease USP15 by Spliceosome Recycling Factor SART3. 2016, Pubmed
Zhang, USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. 2012, Pubmed
Zhao, Ubiquitin-Specific Protease 15 Maintains Transforming Growth Factor-β Pathway Activity by Deubiquitinating Transforming Growth Factor-β Receptor I during Wound Healing. 2019, Pubmed
Zhou, Ubiquitin-specific protease 4 mitigates Toll-like/interleukin-1 receptor signaling and regulates innate immune activation. 2012, Pubmed
Zhou, USP15 potentiates NF-κB activation by differentially stabilizing TAB2 and TAB3. 2020, Pubmed
Zhou, USP15 inhibits multiple myeloma cell apoptosis through activating a feedback loop with the transcription factor NF-κBp65. 2018, Pubmed
Zhou, Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubp12p. 2003, Pubmed
Zou, USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. 2014, Pubmed